The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Targeting the Latent Reservoir for HIV-1
Open accessAbstract
&NA; Antiretroviral therapy can effectively block HIV‐1 replication and prevent or reverse immunodeficiency in HIV‐1‐infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4+ T cells that harbor latent HIV‐1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV‐1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way. &NA; Developing a cure for HIV‐1 requires understanding the mechanisms of HIV‐1 persistence in the latent reservoir. In this review, we discuss historical and recent paradigms in the HIV‐1 persistence field as well as novel immunologic and pharmacologic strategies for eliminating this reservoir.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–315 of 315
The mTOR Complex Controls HIV Latency
Besnard, E., Hakre, S., Kampmann, M., Lim, H. W., Hosmane, N. N., Martin, A., Bassik, M. C., Verschueren, E., Battivelli, E., Chan, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.11.001 · Cited by 199
Self-citationCell Cycle Arrest by Vpr in HIV-1 Virions and Insensitivity to Antiretroviral Agents
Poon, B., Grovit-Ferbas, K., Stewart, S. A., & Chen, I. S. Y. (1998) · Science · doi:10.1126/science.281.5374.266 · Cited by 190
Walker, B., & McMichael, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007054 · Cited by 189
Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion
Bucks, C. M., Norton, J. A., Boesteanu, A. C., Mueller, Y. M., & Katsikis, P. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800997 · Cited by 187
Hermankova, M., Siliciano, J. D., Zhou, Y., Monie, D., Chadwick, K., Margolick, J. B., Quinn, T. C., & Siliciano, R. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7383-7392.2003 · Cited by 187
Self-citationArchin, N. M., Eron, J. J., Palmer, S., Hartmann-Duff, A., Martinson, J. A., Wiegand, A., Bandarenko, N., Schmitz, J. L., Bosch, R. J., Landay, A. L., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6df4 · Cited by 186
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
Huang, S.-H., Ren, Y., Thomas, A. S., Chan, D., Mueller, S., Ward, A. R., Patel, S., Bollard, C. M., Cruz, C. R., Karandish, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97555 · Cited by 185
Self-citationKarn, J. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328340ffbb · Cited by 184
Stability of the Latent Reservoir for HIV‐1 in Patients Receiving Valproic Acid
Siliciano, J. D., Lai, J., Callender, M., Pitt, E., Zhang, H., Margolick, J. B., Gallant, J. E., Cofrancesco, Jr., Moore, R. D., Gange, S. J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511823 · Cited by 182
Self-citationShan, L., Deng, K., Gao, H., Xing, S., Capoferri, A. A., Durand, C. M., Rabi, S. A., Laird, G. M., Kim, M., Hosmane, N. N., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.014 · Cited by 180
Self-citationMacrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells
Baxter, A. E., Russell, R. A., Duncan, C. J. A., Moore, M. D., Willberg, C. B., Pablos, J. L., Finzi, A., Kaufmann, D. E., Ochsenbauer, C., Kappes, J. C., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.010 · Cited by 179
Blankson, J. N., Finzi, D., Pierson, T. C., Sabundayo, B. P., Chadwick, K. R., Margolick, J. B., Quinn, T. C., & Siliciano, R. F. (2000) · The Journal of Infectious Diseases · doi:10.1086/317615 · Cited by 178
Self-citationMultiple Origins of Virus Persistence during Natural Control of HIV Infection
Boritz, E. A., Darko, S., Swaszek, L., Wolf, G., Wells, D., Wu, X., Henry, A. R., Laboune, F., Hu, J., Ambrozak, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.039 · Cited by 178
Cribbs, S. K., Lennox, J., Caliendo, A. M., Brown, L. A., & Guidot, D. M. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0133 · Cited by 177
Leth, S., Schleimann, M. H., Nissen, S. K., Højen, J. F., Olesen, R., Graversen, M. E., Jørgensen, S., Kjær, A. S., Denton, P. W., Mørk, A., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30055-8 · Cited by 177
Kader, M., Wang, X., Piatak, M., Lifson, J., Roederer, M., Veazey, R., & Mattapallil, J. J. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.90 · Cited by 176
Lorenzi, J. C. C., Cohen, Y. Z., Cohn, L. B., Kreider, E. F., Barton, J. P., Learn, G. H., Oliveira, T., Lavine, C. L., Horwitz, J. A., Settler, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617789113 · Cited by 174
Novel Latency Reversal Agents for HIV-1 Cure
Spivak, A. M., & Planelles, V. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-052716-031710 · Cited by 174
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7791 · Cited by 172
McGary, C. S., Deléage, C., Harper, J. L., Micci, L., Ribeiro, S. P., Paganini, S., Kuri-Cervantes, L., Benne, C., Ryan, E. S., BALDERAS, R. S., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.018 · Cited by 172
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo
Horwitz, J. A., Bar‐On, Y., Lu, C.-L., Fera, D., Lockhart, A. A. K., Lorenzi, J. C. C., Nogueira, L., Golijanin, J., Scheid, J. F., Seaman, M. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.048 · Cited by 167
Petrovas, C., Ferrando-Martinez, S., Gerner, M. Y., Casazza, J. P., Pegu, A., Deleage, C., Cooper, A., Hataye, J., Andrews, S., Ambrozak, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2285 · Cited by 165
Pierson, T. C., Hoffman, T. L., Blankson, J. N., Finzi, D., Chadwick, K. R., Margolick, J. B., Buck, C. B., Siliciano, J. D., Doms, R. W., & Siliciano, R. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7824-7833.2000 · Cited by 163
Self-citationArchin, N. M., Cheema, M., Parker, D., Wiegand, A. P., Bosch, R. J., Coffin, J. M., Eron, J. J., Cohen, M. S., & Margolis, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009390 · Cited by 160
Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation
Stewart, S. A., Poon, B., Song, J. Y., & Chen, I. S. Y. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3105-3111.2000 · Cited by 160
Jones, R. B., Mueller, S., O’Connor, R., Rimpel, K., Sloan, D. D., Karel, D., Wong, H. C., Jeng, E. K., Thomas, A. S., Whitney, J. B., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005545 · Cited by 160
Tsai, A., Irrinki, A., Kaur, J., Cihlář, T., Kukolj, G., Sloan, D. D., & Murry, J. P. (2017) · Journal of Virology · doi:10.1128/jvi.02166-16 · Cited by 160
Molecular mechanisms of HIV latency
Cary, D. C., Fujinaga, K., & Peterlin, B. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80565 · Cited by 158
Jiang, G., & Dandekar, S. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0199 · Cited by 152
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells
Ramsuran, V., Naranbhai, V., Horowitz, A., Qi, Y., Martin, M. P., Yuki, Y., Gao, X., Walker-Sperling, V. E. K., Prete, G. Q. D., Schneider, D. K., et al. (2018) · Science · doi:10.1126/science.aam8825 · Cited by 152
Dahl, V., Peterson, J. J., Fuchs, D., Gisslén, M., Palmer, S., & Price, R. W. (2014) · AIDS · doi:10.1097/qad.0000000000000400 · Cited by 150
A mechanistic theory to explain the efficacy of antiretroviral therapy
Laskey, S. B., & Siliciano, R. F. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3351 · Cited by 148
Self-citationSakai, K., Dimas, J., & Lenardo, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509417103 · Cited by 145
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines
Fukazawa, Y., Park, H., Cameron, M. J., Lefebvre, F., Lum, R., Coombes, N., Mahyari, E., Hagen, S. I., Bae, J. Y., Reyes, M. D., et al. (2012) · Nature Medicine · doi:10.1038/nm.2934 · Cited by 144
Byrareddy, S. N., Kallam, B., Arthos, J. A., Cicala, C., Nawaz, F., Hiatt, J. B., Kersh, E. N., McNicholl, J. M., Hanson, D. L., Reimann, K. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3715 · Cited by 143
Gandhi, R. T., & Walker, B. D. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104011 · Cited by 143
Bourgeois, C. F., Kim, Y. K., Churcher, M. J., West, M. J., & Karn, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1079-1093.2002 · Cited by 141
Raha, T., Cheng, S., & Green, M. R. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030044 · Cited by 140
Shedlock, D. J., Silvestri, G., & Weiner, D. B. (2009) · Nature reviews. Immunology · doi:10.1038/nri2636 · Cited by 140
Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation
Cohn, L. B., da Silva, I. T., Valieris, R., Huang, A. S., Lorenzi, J. C. C., Cohen, Y. Z., Pai, J. A., Butler, A. L., Caskey, M. F., Janković, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0017-7 · Cited by 140
Huot, N., Jacquelin, B., García-Téllez, T., Rascle, P., Ploquin, M. J.-Y., Madec, Y., Reeves, R. K., Dereuddre‐Bosquet, N., & Müller-Trutwin, M. C. (2017) · Nature Medicine · doi:10.1038/nm.4421 · Cited by 138
Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells
Sung, J., Pickeral, J., Liu, L., Stanfield-Oakley, S., Lam, C. K., Garrido, C., Pollara, J., LaBranche, C. C., Bonsignori, M., Moody, M. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82314 · Cited by 137
Kharroubi, A. E., Piras, G., Zensen, R., & Martin, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2535 · Cited by 134
Brennan, T. P., Woods, J. O., Sedaghat, A. R., Siliciano, J. D., Siliciano, R. F., & Wilke, C. O. (2009) · Journal of Virology · doi:10.1128/jvi.02568-08 · Cited by 131
Self-citationBudhiraja, S., Famiglietti, M., Bosque, A., Planelles, V., & Rice, A. P. (2012) · Journal of Virology · doi:10.1128/jvi.02413-12 · Cited by 131
Kulkosky, J., Nunnari, G., Otero, M. A., Calarota, S. A., Dornadula, G., Zhang, H., Malin, A., Sullivan, J., Xu, Y., DeSimone, J., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/344357 · Cited by 126
Influence of Host Gene Transcription Level and Orientation on HIV-1 Latency in a Primary-Cell Model
Shan, L., Yang, H., Rabi, S. A., Bravo, H. C., Shroff, N. S., Irizarry, R. A., Zhang, H., Margolick, J. B., Siliciano, J. D., & Siliciano, R. F. (2011) · Journal of Virology · doi:10.1128/jvi.02536-10 · Cited by 123
Self-citationAre T cells the only HIV-1 reservoir?
Kandathil, A. J., Sugawara, S., & Balagopal, A. (2016) · Retrovirology · doi:10.1186/s12977-016-0323-4 · Cited by 123
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease
Cockerham, L. R., Jain, V., Sinclair, E., Glidden, D. V., Hartogenesis, W., Hatano, H., Hunt, P. W., Martin, J. N., Pilcher, C. D., Sékaly, R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000314 · Cited by 121
Calantone, N., Wu, F., Klase, Z. A., Deléage, C., Perkins, M. R., Matsuda, K., Thompson, E. A., Ortiz, A. M., Vinton, C. L., Ourmanov, I., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.014 · Cited by 119
Confining euchromatin/heterochromatin territory: jumonji crosses the line
Tamaru, H. (2010) · Genes & Development · doi:10.1101/gad.1941010 · Cited by 118 · cited 2×
“Resting CD4+ T cells contain high levels of condensed heterochromatin that limit gene expression (Festenstein et al., 2003; Tamaru 2010).”
Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART
Zalar, A., Figueroa, M. I., Ruibal-Ares, B., Baré, P., Cahn, P. E., de Bracco, M. M. D. E., & Belmonte, L. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.05.005 · Cited by 115
Avalos, C. R., Price, S. L., Forsyth, E. R., Pin, J. N., Shirk, E. N., Bullock, B. T., Queen, S. E., Li, M., Gellerup, D. D., O’Connor, S. L., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00290-16 · Cited by 115
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
Gavegnano, C., Brehm, J. H., Dupuy, F. P., Talla, A., Ribeiro, S. P., Kulpa, D. A., Cameron, C., Santos, S., Hurwitz, S. J., Marconi, V. C., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006740 · Cited by 115
The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies
Rice, A. P. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170704130635 · Cited by 113
Targeting the Brain Reservoirs: Toward an HIV Cure
Marban, C., Forouzanfar, F., Aït-Ammar, A., Fahmi, F., Mekdad, H. E., Daouad, F., Rohr, O., & Schwartz, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00397 · Cited by 111
Sloan, D. D., Lam, C. K., Irrinki, A., Liu, L., Tsai, A., Pace, C. S., Kaur, J., Murry, J. P., Balakrishnan, M., Moore, P. A., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005233 · Cited by 110
Hill, A. L., Rosenbloom, D. I. S., Goldstein, E., Hanhauser, E., Kuritzkes, D. R., Siliciano, R. F., & Henrich, T. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005535 · Cited by 110
Self-citationSuccess and failure of the cellular immune response against HIV-1
Migueles, S. A., & Connors, M. (2015) · Nature Immunology · doi:10.1038/ni.3161 · Cited by 109
Reuter, M. A., Estrada, P. M. D. R., Buggert, M., Petrovas, C., Ferrando‐Martínez, S., Nguyen, S., Japp, A. S., Ablanedo‐Terrazas, Y., Rivero-Arrieta, A., Kuri-Cervantes, L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.075 · Cited by 109
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation
Li, P., Kaiser, P. D., Lampiris, H. W., Kim, P., Yukl, S. A., Havlir, D. V., Greene, W. C., & Wong, J. K. (2016) · Nature Medicine · doi:10.1038/nm.4124 · Cited by 108
Cummins, N. W., Sainski, A. M., Dai, H., Natesampillai, S., Pang, Y., Bren, G. D., Correia, M. C. M. D. A., Sampath, R., Rizza, S. A., O’Brien, D. R., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03179-15 · Cited by 104
Wilson, C. C., McKinney, D. M., Anders, M., MaWhinney, S., Forster, J. E., Crimi, C., Southwood, S., Sette, A., Chesnut, R. W., Newman, M. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5611 · Cited by 103
Walker-Sperling, V. E. K., Pohlmeyer, C. W., Tarwater, P. M., & Blankson, J. N. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.019 · Cited by 103
Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Driessche, B. V., Corazza, F., Gatot, J., Mélard, A., Vanhulle, C., Kabeya, K., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505557 · Cited by 101
Asokan, M., Rudicell, R. S., Louder, M. K., McKee, K., O'Dell, S. J., Stewart-Jones, G. B. E., Wang, K., Xu, L., Chen, X., Choe, M., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02097-15 · Cited by 100
Transcription: Insights From the HIV-1 Promoter
Ne, E., Palstra, R.-J. T. S., & Mahmoudi, T. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.07.011 · Cited by 100
Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control
Hersperger, A. R., Migueles, S. A., Betts, M. R., & Connors, M. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283454c39 · Cited by 96
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases
Joosten, S. A., Sullivan, L. C., & Ottenhoff, T. H. M. (2016) · Journal of Immunology Research · doi:10.1155/2016/2695396 · Cited by 96
Frenkel, L. M., Wang, Y., Learn, G. H., McKernan, J. L., Ellis, G. M., Mohan, K. M., Holte, S., Vange, S. M. D., Pawluk, D. M., Melvin, A. J., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5721-5730.2003 · Cited by 93
Astrocytes Resist HIV-1 Fusion but Engulf Infected Macrophage Material
Russell, R. A., Chojnacki, J., Jones, D. M., Johnson, E., Do, T., Eggeling, C., Padilla‐Parra, S., & Sattentau, Q. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.027 · Cited by 93
Lenardo, M. J., Angleman, S. B., Bounkeua, V., Dimas, J., Duvall, M. G., Graubard, M. B., Hornung, F., Selkirk, M. C., Speirs, C. K., Trageser, C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5082-5093.2002 · Cited by 90
Olesen, R., Viganó, S., Rasmussen, T. A., Søgaard, O. S., Ouyang, Z., Buzón, M. J., Bashirova, A. A., Carrington, M. N., Palmer, S., Brinkmann, C. R., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01484-15 · Cited by 88
NF-κB/Rel: agonist and antagonist roles in HIV-1 latency
Chan, J. K., & Greene, W. C. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834124fd · Cited by 82
Lerner, P., Guadalupe, M., Donovan, R. M., Hung, J., Flamm, J., Prindiville, T. P., Sankaran‐Walters, S., Syvanen, M., Wong, J. K., George, M. D., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02409-10 · Cited by 82
Smac mimetics as IAP antagonists
Fulda, S. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.12.005 · Cited by 81
Natural Killer Cell Memory: Progress and Implications
Peng, H. C., & Tian, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01143 · Cited by 81
Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
Sedaghat, A. R., Siliciano, J. D., Brennan, T. P., Wilke, C. O., & Siliciano, R. F. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030122 · Cited by 80
Self-citationHow do viruses control mitochondria-mediated apoptosis?
Neumann, S., Maadidi, S. E., Faletti, L. E., Haun, F., Labib, S., Schejtman, A., Maurer, U., & Borner, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.02.026 · Cited by 80
Barber, S. A., Gama, L., Dudaronek, J. M., Voelker, T., Tarwater, P. M., & Clements, J. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/500983 · Cited by 80
O’Connell, K. A., Han, Y., Williams, T. M., Siliciano, R. F., & Blankson, J. N. (2009) · Journal of Virology · doi:10.1128/jvi.02551-08 · Cited by 79
Self-citationNo evidence of HIV replication in children on antiretroviral therapy
van Zyl, G. U., Katusiime, M. G., Wiegand, A. P., McManus, W. R., Bale, M. J., Halvas, E. K., Luke, B. T., Boltz, V. F., Spindler, J., Laughton, B., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94582 · Cited by 79
HIV Infection of Macrophages: Implications for Pathogenesis and Cure
Clayton, K., Garcia, V., Clements, J. E., & Walker, B. D. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i2.204 · Cited by 77
Yukl, S. A., Sinclair, E., Somsouk, M., Hunt, P. W., Epling, L., Killian, M., Girling, V., Li, P., Havlir, D. V., Deeks, S. G., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000166 · Cited by 74
Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing
Guzzo, C., Ichikawa, D. M., Park, C., Phillips, D. D., Liu, Q., Zhang, P., Kwon, A. L., Miao, H., Lu, J., Rehm, C. A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam7341 · Cited by 73
Identifying the Membrane Proteome of HIV-1 Latently Infected Cells
Berro, R., de la Fuente, C., Klase, Z., Kehn, K., Parvin, L., Pumfery, A., Agbottah, E., Vertes, A., Nekhai, S., & Kashanchi, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606324200 · Cited by 72
LEDGF/p75 Proteins with Alternative Chromatin Tethers Are Functional HIV-1 Cofactors
Meehan, A. M., Saenz, D. T., Morrison, J. H., Garcia-Rivera, J. A., Peretz, M., Llano, M., & Poeschla, E. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000522 · Cited by 72
Laughlin, M. A., Zeichner, S. L., Kolson, D. L., Alwine, J. C., Seshamma, T., Pomerantz, R. J., & González‐Scarano, F. (1993) · Virology · doi:10.1006/viro.1993.1505 · Cited by 72
Re-evaluating evolution in the HIV reservoir
Rosenbloom, D. I. S., Hill, A. L., Laskey, S. B., & Siliciano, R. F. (2017) · Nature · doi:10.1038/nature24634 · Cited by 72
Self-citationHsia, S. V., & Shi, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4043-4052.2002 · Cited by 69
Martin, A. R., Pollack, R. A., Capoferri, A. A., Ambinder, R. F., Durand, C. M., & Siliciano, R. F. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89552 · Cited by 69
Self-citationRanasinghe, S., Lamothe, P. A., Soghoian, D. Z., Kazer, S. W., Cole, M. B., Shalek, A. K., Yosef, N., Jones, R. B., Donaghey, F., Nwonu, C., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.015 · Cited by 68
Antiviral Immunity following Smallpox Virus Infection: a Case-Control Study
Hammarlund, E., Lewis, M. W., Hanifin, J. M., Mori, M., Koudelka, C. W., & Slifka, M. K. (2010) · Journal of Virology · doi:10.1128/jvi.01763-10 · Cited by 67
Gornalusse, G. G., Mummidi, S., Gaitán, Á. A., Jiménez, F., Ramsuran, V., Picton, A. C. P., Rogers, K. C., Manoharan, M. S., Avadhanam, N., Murthy, K. K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423228112 · Cited by 65
Effects of Peptide on NK Cell-Mediated MHC I Recognition
Cassidy, S., Cheent, K. S., & Khakoo, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00133 · Cited by 64
Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection
Koizumi, Y., Ohashi, H., Nakajima, S., Tanaka, Y., Wakita, T., Perelson, A. S., Iwami, S., & Watashi, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610197114 · Cited by 58
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
Henrich, T. J., Hobbs, K. S., Hanhauser, E., Scully, E. P., Hogan, L. E., Robles, Y., Leadabrand, K. S., Marty, F. M., Palmer, C. D., Jost, S., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix265 · Cited by 54
BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
Lu, P., Shen, Y., Yang, H. B., Wang, Y., Jiang, Z., Yang, X., Zhong, Y., Pan, H., Xu, J., Lu, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16816-1 · Cited by 52
In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific
Demoustier, A., Gubler, B., Lambotte, O., de Herve, M.-G. D. G., Wallon, C., Goujard, C., Delfraissy, J., & Taoufik, Y. (2002) · AIDS · doi:10.1097/00002030-200209060-00006 · Cited by 46
Mujib, S., Liu, J., Rahman, A. K. M. N.-U., Schwartz, J. A., Bonner, P., Yue, F. Y., & Ostrowski, M. (2017) · Journal of Virology · doi:10.1128/jvi.00634-17 · Cited by 44
Kiniry, B. E., Ganesh, A., Critchfield, J. W., Hunt, P. W., Hecht, F. M., Somsouk, M., Deeks, S. G., & Shacklett, B. L. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.100 · Cited by 43
HIV-1 viral genes and mitochondrial apoptosis
Shedlock, D. J., Hwang, D. S., Choo, A. Y., Chung, C. W., Muthumani, K., & Weiner, D. B. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0239-0 · Cited by 42
Lymphocyte kinetics in health and disease
Asquith, B., Borghans, J. A. M., Ganusov, V. V., & Macallan, D. C. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.01.003 · Cited by 42
Vojnov, L., Martins, M. A., Bean, A. T., de Santana, M. G. V., Sacha, J. B., Wilson, N. A., Bonaldo, M. C., Galler, R., Stevenson, M., & Watkins, D. I. (2012) · Journal of Virology · doi:10.1128/jvi.06324-11 · Cited by 42
Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections
DiNapoli, S. R., Hirsch, V. M., & Brenchley, J. M. (2016) · Journal of Virology · doi:10.1128/jvi.00672-16 · Cited by 42
Hua, S., Viganó, S., Tse, S. Y., Ouyang, Z., Harrington, S., Negron, J., García‐Broncano, P., Marchetti, G. C., Genebat, M., Leal, M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1111 · Cited by 41
Mujib, S., Saiyed, A., Fadel, S., Bozorgzad, A., Aidarus, N., Yue, F. Y., Benko, E., Kovacs, C., Emert‐Sedlak, L. A., Smithgall, T. E., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93684 · Cited by 36
Spivak, A. M., Larragoite, E. T., Coletti, M. L., Macedo, A. B., Martins, L. J., Bosque, A., & Planelles, V. (2016) · Retrovirology · doi:10.1186/s12977-016-0319-0 · Cited by 32
Tapia, G., Højen, J. F., Ökvist, M., Olesen, R., Leth, S., Nissen, S. K., VanBelzen, J., O’Doherty, U., Mørk, A., Krogsgaard, K., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.09.004 · Cited by 32
Therapeutic Efficacy of Vectored PGT121 Gene Delivery in HIV-1-Infected Humanized Mice
Badamchi-Zadeh, A., Tartaglia, L. J., Abbink, P., Bricault, C. A., Liu, P.-T., Boyd, M. B., Kirilova, M., Mercado, N. B., Nanayakkara, O., Vrbanac, V. D., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01925-17 · Cited by 32
Rainho-Tomko, J. N., Martins, M. A., Cunyat, F., Watkins, I. T., Watkins, D. I., & Stevenson, M. (2015) · Journal of Virology · doi:10.1128/jvi.01699-15 · Cited by 29
Ciudad, M. T., Sorvillo, N., van Alphen, F. P. J., Catalán, D., Meijer, A. B., Voorberg, J., & Jaraquemada, D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.6hi0216-069r · Cited by 28
Sung, J., Sholtis, K., Kirchherr, J., Kuruc, J. D., Gay, C. L., Nordstrom, J. L., Bollard, C. M., Archin, N. M., & Margolis, D. M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.07.019 · Cited by 28
Shasha, D., & Walker, B. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00162 · Cited by 27
Bruel, T., Hamimi, C., Dereuddre‐Bosquet, N., Cosma, A., Shin, S. Y., Corneau, A., Versmisse, P., Karlsson, I., Malleret, B., Targat, B., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03723-14 · Cited by 23
Cited by
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
Ganor, Y., Real, F., Sennepin, A., Dutertre, C.-A., Prevedel, L., Xu, L., Tudor, D., Charmeteau, B., Couedel-Courteille, A., Marion, S., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0335-z · Cited by 303
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
Chaillon, A., Gianella, S., Dellicour, S., Rawlings, S. A., Schlub, T. E., De Oliveira, M. F., Ignacio, C., Porrachia, M., Vrancken, B., & Smith, D. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134815 · Cited by 250
Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Rohr, O., & Van Lint, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03060 · Cited by 163
Lu, C.-L., Pai, J. A., Nogueira, L., Mendoza, P., Gruell, H., Oliveira, T. Y., Barton, J., Lorenzi, J. C. C., Cohen, Y. Z., Cohn, L. B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813512115 · Cited by 77
Metadata
- Authors
- Sengupta, S., & Siliciano, R. F.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 48
- Issue
- 5
- Pages
- 872-895
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2804663340
- Cited by
- 340
- References
- 315
- FWCI
- 21.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.